HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins.

Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various cancer cells. Hsp90 is known to be involved in cell survival and growth in tumor cells. Nevertheless, Hsp90 inhibitors exhibit a variable effect on the cytotoxicity of anticancer drugs. Furthermore, the combined effect of Hsp90 inhibitors on TRAIL-induced apoptosis in epithelial ovarian cancer cells has not been determined. To assess the ability of an inhibitor of Hsp90 inhibitor radicicol to promote apoptosis, we investigated the effect of radicicol on TRAIL-induced apoptosis in the human epithelial ovarian carcinoma cell lines OVCAR-3 and SK-OV-3. TRAIL induced a decrease in Bid, Bcl-2, Bcl-xL, and survivin protein levels, increase in Bax levels, loss of the mitochondrial transmembrane potential, cytochrome c release, activation of caspases (-8, -9, and -3), cleavage of PARP-1 and an increase in the tumor suppressor p53 levels. Radicicol enhanced TRAIL-induced apoptosis-related protein activation, nuclear damage and cell death. These results suggest that radicicol may potentiate the apoptotic effect of TRAIL on ovarian carcinoma cell lines by increasing the activation of the caspase-8- and Bid-dependent pathway and the mitochondria-mediated apoptotic pathway, leading to caspase activation. Radicicol may confer a benefit in the TRAIL treatment of epithelial ovarian adenocarcinoma.
AuthorsYun Jeong Kim, Seon Ae Lee, Soon Chul Myung, Wonyong Kim, Chung Soo Lee
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 359 Issue 1-2 Pg. 33-43 (Jan 2012) ISSN: 1573-4919 [Electronic] Netherlands
PMID21800052 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • BH3 Interacting Domain Death Agonist Protein
  • BID protein, human
  • Enzyme Inhibitors
  • HSP90 Heat-Shock Proteins
  • Macrolides
  • TNF-Related Apoptosis-Inducing Ligand
  • Caspases
  • monorden
Topics
  • Antineoplastic Agents
  • Apoptosis (drug effects)
  • Apoptosis Regulatory Proteins (drug effects, metabolism)
  • BH3 Interacting Domain Death Agonist Protein (metabolism)
  • Carcinoma, Ovarian Epithelial
  • Caspases (metabolism)
  • Cell Line, Tumor
  • Enzyme Inhibitors
  • Female
  • HSP90 Heat-Shock Proteins (antagonists & inhibitors)
  • Humans
  • Macrolides (pharmacology)
  • Mitochondria
  • Neoplasms, Glandular and Epithelial (drug therapy, pathology)
  • Ovarian Neoplasms (drug therapy, pathology)
  • TNF-Related Apoptosis-Inducing Ligand (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: